OSIRIS MEDICAL IMAGING LLPActive

Company number SO300845Limited liability partnershipIncorporated 2006

Key figures

£9,400-66.2%
Net assets 2025/26
-17.2%
Average annual change 2021/22–2025/26
020 k40 k60 k2021/222022/232023/242024/252025/26

Like most small UK companies, OSIRIS MEDICAL IMAGING LLP does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k60 kpuudub2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand18,89111,48025,55319,0519,400
Total assets—————
Total liabilities—————
Net assets / total equity19,96119,73441,55527,8459,400
Average number of employees33333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the LLP during the financial year was that of medical imaging services. The LLP ceased trading on 30 June 2025 and it is the intention of the members to wind up the LLP.

As described in the company's latest filed accounts.

Summary: OSIRIS MEDICAL IMAGING LLP

Company

OSIRIS MEDICAL IMAGING LLP is a limited liability partnership registered with Companies House under company number SO300845. It was incorporated on 10 Mar 2006. Its status is active. The registered office is in Aberdeen (AB10).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £9,400, down 66.2% on the previous year. Cash at bank and in hand was £9,400. The company had an average of 3 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

3 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 19 Mar 2027.